Evogene Ltd. current report, Q2 FY2017

Business Context and Reporting Period

This Form 6-K filing by Evogene Ltd. covers the month of June 2017. The document serves as a notice regarding the company's Annual General Meeting of Shareholders, scheduled to be held on Tuesday, July 18, 2017, at 3:00 p.m. Israel time at the company's offices in Rehovot, Israel.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing to announce a shareholder meeting and does not contain financial statements or performance data.

Material Changes

No material changes to financial performance or operations are reported in this document. The filing focuses solely on the administrative details of the upcoming shareholder meeting.

Guidance, Outlook, and Risks

Management commentary, financial guidance, outlook, risks, contingencies, and unusual items are not addressed in this filing. The document includes references to the Notice of the Meeting, Proxy Statement, and Form of Proxy Card as exhibits.

Key Facts for Investors to Verify

  • Annual General Meeting date: July 18, 2017.
  • Meeting location: Evogene offices, 13 Gad Feinstein Street, Park Rehovot, Rehovot, Israel.
  • Meeting time: 3:00 p.m. Israel time.
  • Availability of meeting materials (Notice, Proxy Statement, Proxy Card) on the company website at investors.evogene.com/sec-filings.